Publications by authors named "Donald M Gleason"

Claim this Profile
C
Continuing benefit of zoledronic acid in preventing skeletal complications in patients with bone metastases.
Fred Saad, Yin-Miao Chen, Donald M Gleason, Joseph Chin

Clin Genitourin Cancer· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer.
Fred Saad, Donald M Gleason, Robin Murray, Simon Tchekmedyian, Peter Venner

J Natl Cancer Inst· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized controlled trial of zoledronic acid to prevent bone loss in men receiving androgen deprivation therapy for nonmetastatic prostate cancer.
Matthew R Smith, James Eastham, Donald M Gleason, Daniel Shasha, Simon Tchekmedyian

J Urol· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma.
Fred Saad, Donald M Gleason, Robin Murray, Simon Tchekmedyian, Peter Venner

J Natl Cancer Inst· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis